SC
LLY icon

Stralem & Co’s Eli Lilly LLY Stock Holding History

Stralem & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-11,200
Closed -$956K – 47
2018
Q2 		$956K Hold
11,200
– – 0.28% 38
2018
Q1 		$867K Buy
11,200
+600
+6% +$48.3K 0.17% 38
2017
Q4 		$895K Sell
10,600
-2,600
-20% -$221K 0.15% 42
2017
Q3 		$1.13M Buy
13,200
+600
+5% +$49.2K 0.16% 40
2017
Q2 		$1.04M Hold
12,600
– – 0.12% 42
2017
Q1 		$1.06M Hold
12,600
– – 0.12% 40
2016
Q4 		$927K Hold
12,600
– – 0.11% 42
2016
Q3 		$1.01M Sell
12,600
-4,100
-25% -$328K 0.12% 41
2016
Q2 		$1.31M Hold
16,700
– – 0.15% 39
2016
Q1 		$1.2M Hold
16,700
– – 0.13% 39
2015
Q4 		$1.41M Buy
+16,700
New +$1.39M 0.14% 40

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stralem & Co's LLY Position: Q3 2018 in Review

Stralem & Co sold out of Eli Lilly (LLY) in Q3 2018, closing a stake of 11,200 shares — an estimated $956K sold.

Stralem & Co first reported a position in LLY in Q4 2015 and held it in 11 quarters. The position peaked at $1.41M in Q4 2015. 1,432 funds tracked by Wall St. Rank hold LLY as of Q3 2018.

  • Stralem & Co reported no remaining Eli Lilly position as of Q3 2018 after selling out during the quarter.
  • Stralem & Co sold 11,200 Eli Lilly shares in Q3 2018, an estimated $956K.
  • Stralem & Co first reported a position in Eli Lilly in Q4 2015 and held it in 11 quarters.
  • Stralem & Co's Eli Lilly position peaked at $1.41M in Q4 2015.
  • 1,432 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2018.

Based on Stralem & Co's 13F filing for Q3 2018, filed 17 Oct 2018.